Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Septerna

Biotech & Life Sciences · San Francisco, United States · Founded 2022 · IPO 2024 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$685M
Market cap · Apr/2026
Revenue
$46M
Latest reported FY

Investors

16 investors on Septerna's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 7 investors entered at this stage
BVF Partners
Invus
Logos Capital
Casdin Capital
Catalio Capital Management
Samsara BioCapital
Third Rock Ventures
Series B+ 9 investors entered at this stage
Soleus Capital
Monash University
Goldman Sachs Asset Management
Driehaus Capital Management
Mirae Asset Capital
RA Capital Management
Deep Track Capital
Woodline Partners
Vertex Ventures HC

Global footprint

Where Septerna has talent and traffic

Web traffic by country
14K monthly visits
across markets
🇺🇸 United States47.1%
🇨🇳 China45%
🇮🇳 India7.9%
🇪🇸 Spain2.9%
Top 4 markets shown

See Septerna on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo